InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-09-11 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-08-04 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-07-22 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2022-05-27 | Earl Blumenauer | house | Purchase | $15,001 - $50,000 |
No financial data available for SNY.
Company may not file with SEC or CIK is unresolved.
A Look At Novavax (NVAX) Valuation As It Shifts To Licensing And Awaits Combo Vaccine Data
The 28th China Beijing International High-Tech Expo Grand Opening Soon
KYMR Q1 Earnings Top Estimates, Revenues Gain on GILD Collaboration
FDA said to have named Katherine Szarama as acting CBER chief
Systemic Mastocytosis (SM) Treatment Market 2026-2035: Industry to More Than Double in Size, Led by Sanofi, AdvaCare Pharma, and Cogent Biosciences
What the U.S. Pharmaceutical Industry Could Learn from How Africa Solves Patient Access
Sanofi (ENXTPA:SAN) Valuation After Cenrifki Progress New CEO Appointment And Stronger Dupixent Momentum
Kymera Therapeutics Q1 Earnings Call Highlights
Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?
Regeneron drops despite Q1 beat, $3B share buyback program
Recursion Pharmaceuticals May Be Losing Ground To Its Peers
Regeneron: Catching Another Wind